After terminating 1 of 2 late-stage sickle cell disease trials, Pfizer still expects FDA approval in 2026

0

27.03.2024 00:12

Fiercebiotech.com

After terminating 1 of 2 late-stage sickle cell disease trials, Pfizer still expects FDA approval in 2026 gmasson Tue, 03/26/2024 - 17:12

СМИ24.net — правдивые новости, непрерывно 24/7 на русском языке с ежеминутным обновлением *